Filter
744
Text search:
drug
manufacturing
Featured
Recommendations
60
New Publications
187
Language
Document type
No document type
360
Studies & Reports
141
Guidelines
129
Manuals
44
Strategic & Response Plan
41
Fact sheets
11
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Global
37
India
35
Kenya
32
Nigeria
21
Ghana
21
Uganda
19
Ethiopia
17
Sierra Leone
13
Tanzania
13
South Africa
13
Western and Central Europe
13
Nepal
12
Zambia
12
Bangladesh
12
Africa
11
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Rwanda
7
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Indonesia
5
Latin America and the Carribbean
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Vietnam
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Uzbekistan
1
Australia
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
303
Clinical Guidelines
58
Pharmacy & Technologies
33
Public Health
27
Key Resources
20
Women & Child Health
13
Capacity Building
6
Toolboxes
Pharmacy
83
AMR
81
COVID-19
53
HIV
46
TB
38
Mental Health
34
Malaria
23
NTDs
20
Planetary Health
16
Ebola & Marburg
14
NCDs
13
Health Financing Toolbox
12
Rapid Response
11
Global Health Education
11
Conflict
5
Specific Hazards
5
Caregiver
5
2.0 Rapid Response
5
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
The Quadripartite organizations have developed the One Health Priority Research Agenda for AMR report, this is a joint initiative to assist in directing and catalysing scientific interest and financial investments for the priority research agenda across sectors for countries and funding bodies. The
...
The potential for terrorist use of chemical agents is a noted concern highlighted by the Tokyo sarin gas attacks of 1995. The events of September 11, 2001, increased congressional attention towards reducing the vulnerability of the United States to such unconventional attacks. The
possibility that
...
The core of the strategy is the goal for all patients to have better overall care, so that the numbers of deaths and cases of disability are reduced by 50% before 2030. For this to be achieved, four strategic aims will be pursued.
Empower and engage communities,
Ensure safe, effective trea
...
SHOPS and HIA finalized a scope of work with USAID Senegal in April 2015, and a team of five private sector experts conducted the onsite assessments between May and June 2015. The Private Sector Assessment (PSA) team worked closely with Senegalese key stakeholders throughout the process. The PSA tea
...
While much progress has been achieved over the past year, the Region of the Americas has stubbornly remained the epicenter of the COVID-19 pandemic. PAHO is launching its 2021 COVID-19 Response Strategy and Donor Appeal to continue supporting Latin American and Caribbean countries and territories i
...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adequate to protect people from COVID-19. The time it t
...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu
...
Updated version – September 2020
The COVID-19 pandemic is affecting everyone. Globally, millions of people have been infected with the virus, while hundreds of thousands have lost their lives. In Moldova, the pandemic is placing an ever-increasing pressure on the health care and social protectio
...
3 February 2021
Vaccine- and vaccination-related crises require a communication response that is different from the communication strategies used to promote the benefits and importance of vaccines in general. This document presents the technical guidance needed to develop a communication plan that
...
Why bold action against inequalities is needed to en AIDS, stop COVID-19 and prepare for future pandemics
The number of new Ebola infections in Sierra Leone is declining, despite the outbreak continuing to claim lives. New cases have dropped to around 9-12 per week, according to recent WHO figures. There were over 500 cases per week at the height of the crisis around late November 2014.
The impact on t
...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health risks in their given health risk assessment contexts
...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a
...
Antimicrobials are precious agents for combating infectious diseases and had saved millions of lives throughout the world. However, the current trend of increasing antimicrobial resistance (AMR) has become a global health problem with increased morbidity and mortality in infectious diseases. Sri La
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
